Brownsburg, IN, United States of America

Douglas E Prather


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 77(Granted Patents)


Company Filing History:


Years Active: 1995-1996

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Douglas E. Prather: Innovator in Pharmaceutical Sciences

Introduction

Douglas E. Prather is a notable inventor based in Brownsburg, Indiana, known for his significant contributions to the field of pharmaceutical sciences. With a total of three patents to his name, he has focused his research on innovative compounds that benefit medical science.

Latest Patents

One of Prather's recent patents is related to Loracarbef hydrochloride C1-C3 alcohol solvates and their various uses. This invention provides crystalline hydrochloride C1-C3 alcohol solvate forms of a specific compound, particularly highlighting the crystalline hydrochloride forms with ethanol, methanol, and propanol solvates. Additionally, the patent discloses processes for preparing and utilizing these compounds, showcasing his commitment to advancing pharmaceutical applications.

Career Highlights

Douglas E. Prather is associated with Eli Lilly and Company, a leading global pharmaceutical company known for its innovative healthcare solutions. His work at Eli Lilly emphasizes the company's dedication to research and development in creating effective therapeutic alternatives.

Collaborations

Throughout his career, Prather has worked closely with notable colleagues such as Jane G. Amos and Perry C. Heath. Their collaborative efforts enhance the innovative capacity of their projects, fostering an environment conducive to breakthrough inventions in the industry.

Conclusion

Douglas E. Prather stands out as an influential inventor in the pharmaceutical landscape. His work demonstrates a commitment to innovation, with patents that hold potential for significant impact in medical treatments. As he continues to collaborate with dedicated professionals, the future looks promising for his ongoing contributions to pharmaceutical sciences.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…